Categories: All postsCannabis

Village Farms is the best-positioned Canadian LP, Beacon says

Village Farms CEO Mike DeGiglio
Facing a tough macro environment, Village Farms (Village Farms Stock Quote, Chart, News TSX:VFF) and its cannabis-growing subsidiary Pure Sunfarms pass a major stress test with its latest quarterly results, according to Beacon Securities analyst Doug Cooper.

In an update to clients on Friday, Cooper reiterated his “Buy” rating but dropped his target price from C$55.00 to C$40.00, saying that Pure Sunfarms is clearly the best-positioned licensed cannabis producer in Canada.

Vancouver-based vegetable and cannabis grower Village Farms reported its third quarter financials last Thursday, showing produce sales of $38.3 million, down from $39.7 million a year earlier. The company’s overall net loss before tax was $6.5 million which included the loss from Pure Sunfarms, the company’s 50-per-cent owned joint venture with Emerald Health. (All figures in US dollars unless where noted otherwise.)

In its quarterly comments, management pointed out that PSF was the top-performing brand of dried flower by both kilograms sold and dollar sales with the Ontario Cannabis Store for the month of October, garnering 16 per cent of market share by kgs sold.

“We are pleased to report another quarter in which Pure Sunfarms continued to set the standard for performance as a best-in-class cannabis operation, which again drove strong financial performance,” said Village Farms CEO Michael DeGiglio in a press release.

“Pure Sunfarms’ achieved its fourth consecutive quarter of positive EBITDA, with an industry leading all-in cost of production of C$0.63, gross margin of 69 per cent and EBITDA margin of 56 per cent. In the 12 months since adult-use cannabis was legalized in Canada in October 2018, Pure Sunfarms has already generated C$47 million in EBITDA, an especially impressive number given that its operations were ramping up throughout most of that period,” DeGiglio said.

In his update, Cooper did not say whether the quarter did or did not meet his expectations on revenue and EBITDA but the analyst compared VFF’s results with those of other licensed producers in Canada, showing that not only did PSF have by far the largest volume over the quarter at 12,000 kg sold (the next-largest was Sundial at 7,944 kg) but that at an estimated price of $2 per gram, PSF’s business model was truly stress-tested over the quarter and came out fine, showing proforma gross margin of 76 per cent and an industry-leading cost per gram of $0.63.

Cooper says there is no doubt that the future direction of cannabis prices is lower and, moreover, that many other companies in the industry are not positioned to deal with substantially lower prices. But PSF has proven in its Q3 that it can come out EBITDA positive.

“The Q3 reporting season is separating the strong from the weak,” writes Cooper. “We continue to believe that at the end of the day, there will be three to five Canadian players who will control 90 per cent of the market. While roll-out of stores has been slower than expected, we still believe the Canadian cannabis market will be multi-billion dollar.”

“PSF’s Q3 results indicate that it is the strongest LP in Canada in terms of product sold, low-cost producer, ability to scale and the balance sheet to support it and its model has now been stress-tested at a price/g of $2 – a test no other LP would pass,” he writes.

Cooper says that the expected lower selling prices will impact PSF’s sales going forward, however, which in turn have resulted in a decrease in the analyst’s EBITDA forecast for VFF for the years 2019 to 2021.

Consequently, Cooper’s target is down to C$40.00 per share, which at press time represented a projected 12-month return of 372 per cent.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vff
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

7 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

14 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

15 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

16 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago